Year archive

Pharming Group N.V. — 2024 filings

All 60 regulatory filings released by Pharming Group N.V. (PHARM) in 2024, sourced directly from the official regulator.

60 Filings

2024 Period

2024 filings (60)

Filing	Released	Lang
6-K Foreign Filer Report	2024-12-16	English
6-K Foreign Filer Report	2024-12-11	English
PHARMING GROUP N.V. Major Shareholding Notification	2024-11-14	English
MS INITIAL Major Shareholding Notification	2024-11-08	English
6-K Foreign Filer Report	2024-10-24	English
Pharming Group reports third quarter 2024 financial results and provides business update Earnings Release Q3 2024	2024-10-24	Dutch
Pharming Group reports third quarter 2024 financial results and provides business update Earnings Release Q3 2024	2024-10-24	English
6-K Foreign Filer Report	2024-10-10	English
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation Regulatory Filings	2024-10-10	Dutch
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation Regulatory Filings	2024-10-10	English
6-K Foreign Filer Report	2024-09-26	English
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib) Earnings Release FY 2023	2024-09-26	Dutch
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib) Regulatory Filings	2024-09-26	English
6-K Foreign Filer Report	2024-08-01	English
Pharming Group reports second quarter and first half 2024 financial results and provides business update Earnings Release H1 2024	2024-08-01	Dutch
Pharming Group reports second quarter and first half 2024 financial results and provides business update Earnings Release H1 2024	2024-08-01	English
Earnings Release 2024 Earnings Release H1 2024	2024-08-01	English
Pharming Group to report second quarter and first half 2024 financial results on August 1 Report Publication Announcement	2024-07-18	Dutch
Pharming Group to report second quarter and first half 2024 financial results on August 1 Report Publication Announcement	2024-07-18	English
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union Regulatory Filings	2024-05-31	Dutch
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union Regulatory Filings	2024-05-31	English
6-K Foreign Filer Report	2024-05-30	English
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders AGM Information	2024-05-22	Dutch
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders AGM Information	2024-05-22	English
6-K Foreign Filer Report	2024-05-21	English
6-K Foreign Filer Report	2024-05-15	English
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025 Capital/Financing Update	2024-05-15	Dutch
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025 Capital/Financing Update	2024-05-15	English
6-K Foreign Filer Report	2024-05-08	English
Pharming Group reports first quarter 2024 financial results and provides business update Earnings Release Q1 2024	2024-05-08	Dutch
Pharming Group reports first quarter 2024 financial results and provides business update Earnings Release Q1 2024	2024-05-08	English
Annual Report (ESEF) 2023 Annual Report (ESEF) FY 2023	2024-05-02	English
6-K Foreign Filer Report	2024-04-25	English
6-K Foreign Filer Report	2024-04-24	English
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards Regulatory Filings	2024-04-24	Dutch
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards Regulatory Filings	2024-04-24	English
Pharming Group to report first quarter 2024 financial results on May 8 Report Publication Announcement	2024-04-24	Dutch
Pharming Group to report first quarter 2024 financial results on May 8 Report Publication Announcement	2024-04-24	English
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 Transaction in Own Shares	2024-04-22	Dutch
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 Transaction in Own Shares	2024-04-22	English
Pharming Group announces the placement of €100 million convertible bonds due 2029 Capital/Financing Update	2024-04-19	Dutch
Pharming Group announces the placement of €100 million convertible bonds due 2029 Capital/Financing Update	2024-04-19	English
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 Capital/Financing Update	2024-04-18	Dutch
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 Capital/Financing Update	2024-04-18	English
6-K Foreign Filer Report	2024-04-08	English
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib Regulatory Filings	2024-04-08	Dutch
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib Regulatory Filings	2024-04-08	English
6-K Foreign Filer Report	2024-04-04	English
20-F Annual Report FY 2023	2024-04-04	English
Pharming Group announces the 2024 Annual General Meeting of Shareholders AGM Information	2024-04-04	Dutch
Pharming Group announces the 2024 Annual General Meeting of Shareholders AGM Information	2024-04-04	English
Pharming Group announces the filing of its 2023 Annual Report and Form 20-F Report Publication Announcement	2024-04-04	Dutch
Pharming Group announces the filing of its 2023 Annual Report and Form 20-F Report Publication Announcement	2024-04-04	English
6-K Foreign Filer Report	2024-03-14	English
Pharming Group reports fourth quarter and full year 2023 financial results Earnings Release FY 2023	2024-03-14	Dutch
Pharming Group reports fourth quarter and full year 2023 financial results Earnings Release Q4 2023	2024-03-14	English
PHARMING GROUP N.V. Major Shareholding Notification	2024-02-14	English
6-K Foreign Filer Report	2024-01-08	English
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update Earnings Release FY 2023	2024-01-08	Dutch
Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update Earnings Release FY 2023	2024-01-08	English

Filings by year

2026 29 filings
2025 60 filings
2024 60 filings
2023 64 filings
2022 56 filings
2021 48 filings
2020 44 filings
2019 17 filings
2018 18 filings
2017 22 filings
2016 25 filings
2015 21 filings
2014 19 filings
2013 26 filings
2012 59 filings
2011 34 filings
2010 52 filings
2009 40 filings
2008 29 filings
2007 44 filings
2006 23 filings
2005 6 filings